<DOC>
	<DOCNO>NCT02199431</DOCNO>
	<brief_summary>The purpose study evaluate increase exposure Lu AF11167 follow single oral dose Lu AF11167 without administration multiple oral dos itraconazole ( strong CYP3A4/5 inhibitor ) healthy subject infer metabolic status CYP2C19 extensive metabolisers</brief_summary>
	<brief_title>Study Evaluate Effect Known Marketed Product , Itraconazole ( Mycosis Treatment ) Lu AF11167 Entering Body Subsequently Elimination . The Study Drug-drug Interaction Study Healthy Volunteers .</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>Subjects 18 year age 55 year age BMI &gt; 18.5 kg/m2 &lt; 30.0 kg/m2 Screening Visit . Women must pregnant lactating . Other predefined inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Lu AF11167</keyword>
	<keyword>Interaction</keyword>
</DOC>